首页> 外文OA文献 >Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective

【2h】

Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective

机译：在甲状腺癌前甲状腺癌前的放射性碘烧蚀前使用重组人TSH的成本效益，与甲状腺功能亢进的治疗患者：德国视角

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P Mernagh; S Campbell; M Dietlein; M Luster; E Mazzaferri; A R Weston;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up [J] . Eleonora Molinaro, Carlotta Giani, Laura Agate, The journal of clinical endocrinology and metabolism . 2013,第7期

机译：重组人TSH或甲状腺激素治疗退出后接受低碘131I放射性碘甲状腺消融的分化型甲状腺癌患者在随访10年后仍显示相同的结果
2. Cost-effectiveness of using recombinant human thyroid-stimulating hormone before radioiodine ablation for thyroid cancer: the Canadian perspective. [J] . Mernagh P, Suebwongpat A, Silverberg J, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2010,第2期

机译：在放射碘消融治疗甲状腺癌之前使用重组人促甲状腺激素的成本效益：加拿大的观点。
3. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. [J] . Taieb D, Sebag F, Cherenko M, Clinical Endocrinology . 2009,第1期

机译：接受重组人TSH（rhTSH）接受放射性碘残留消融（RRA）的甲状腺癌患者的生活质量变化和临床结局：一项随机对照研究。
4. Clinical Engineering and Clinical Dosimetry in Patients with Differentiated Thyroid Cancer Undergoing Thyroid Remnant Ablation with Radioiodine-131 [C] . M. Medvedec, D. Dodig 12th Mediterranean conference on medical and biological engineering and computing 2010 . 2010

机译：放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
5. Risk Factors of Salivary Gland Dysfunction in Radioiodine Treated Thyroid Cancer Patients and Automation of SPECT/CT Imaging Analysis of Mouse Thyroid [D] . Hollingsworth, Brynn Anne. 2017

机译：放射性碘治疗甲状腺癌患者唾液腺功能障碍的危险因素及小鼠甲状腺的SPECT / CT成像自动化
6. Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective [O] . Seo Young Sohn, Hye Won Jang, Yoon Young Cho, 2015

机译：甲状腺癌放射性碘消融前重组人甲状腺刺激激素刺激与甲状腺激素撤除的经济评价：韩国的观点
7. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. [O] . Molinaro E, Giani C, Agate L, 2013

机译：重组人TSH或甲状腺激素治疗停药后，接受放射性碘甲状腺消融术并以低活性13 I消散的分化型甲状腺癌患者在10年的随访中显示出相同的结果。
8. Feasibility Study of Thyroid Cancer among Patients Treated with I-131 [R] . Anderson, T. W. 1984

机译：I-131治疗患者甲状腺癌的可行性研究

Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective

著录项

引文网络

相似文献

相关主题

期刊订阅